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Abstract
Purpose The purpose of the present study was to systematically review the complex associations between energy balance-
related factors and breast cancer risk, for which previous evidence has suggested different associations in the life course of 
women and by hormone receptor (HR) status of the tumor.
Methods Relevant publications on adulthood physical activity, sedentary behavior, body mass index (BMI), waist and hip 
circumferences, waist-to-hip ratio, and weight change and pre- and postmenopausal breast cancer risk were identified in 
PubMed up to 30 April 2017. Random-effects meta-analyses were conducted to summarize the relative risks across studies.
Results One hundred and twenty-six observational cohort studies comprising over 22,900 premenopausal and 103,000 post-
menopausal breast cancer cases were meta-analyzed. Higher physical activity was inversely associated with both pre- and 
postmenopausal breast cancers, whereas increased sitting time was positively associated with postmenopausal breast cancer. 
Although higher early adult BMI (ages 18–30 years) was inversely associated with pre- and postmenopausal breast cancers, 
adult weight gain and greater body adiposity increased breast cancer risk in postmenopausal women, and the increased risk 
was evident for HR+ but not HR− breast cancers, and among never but not current users of postmenopausal hormones. The 
evidence was less consistent in premenopausal women. There were no associations with adult weight gain, inverse associa-
tions with adult BMI (study baseline) and hip circumference, and non-significant associations with waist circumference 
and waist-to-hip ratio that were reverted to positive associations on average in studies accounting for BMI. No significant 
associations were observed for HR-defined premenopausal breast cancers.
Conclusion Better understanding on the impact of these factors on pre- and postmenopausal breast cancers and their subtypes 
along the life course is needed.
Keywords Systematic literature review · Breast cancer · Life course · Adiposity · Weight change · Physical activity
Introduction
Globally, breast cancer is the most frequent cancer and the 
leading cause of cancer death in women. There were an esti-
mated 2.09 million incident cases and 0.63 million deaths 
from breast cancer worldwide in 2018 [1], which imposes 
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a considerable burden on public health. While mammogra-
phy screening reduces breast cancer mortality by up to 40 
percent [2], cancer prevention via lifestyle modifications is 
clearly needed [3]. Overweight and obesity—globally prev-
alent conditions [4, 5]—manifested by chronic excessive 
energy intake and inadequate energy expenditure through 
low physical activity and increased sedentary behavior [6] 
could be one such target. Physical activity is also an impor-
tant focus, as it may influence breast cancer risk through 
mechanisms in addition to body weight modulation [7].
The Third Expert Report published by the World Can-
cer Research Fund/American Institute for Cancer Research 
(WCRF/AICR) concluded that there is strong evidence that 
vigorous physical activity protects against premenopausal 
breast cancer, moderate or vigorous physical activity pro-
tects against postmenopausal breast cancer, and greater 
body fatness and weight gain in adult life causes postmeno-
pausal breast cancer (https ://www.wcrf.org/dieta ndcan cer) 
[8]. These conclusions supported the recommendations 
for cancer prevention which promote healthy body weight 
(World Health Organisation definition: 18.5 to 24.9 kg/m2) 
and adequate energy balance throughout life (be physically 
active, eat a diet rich in wholegrains, vegetables, fruit and 
beans, limit consumption of ‘fast foods’ and other processed 
foods high in fat, starches or sugars, and sugar sweetened 
drinks). Previous studies have shown that adherence to the 
2007 WCRF/AICR recommendations [9] is associated with 
reduced breast cancer risk [10–17], breast cancer mortality 
[18] and total mortality [19], and improved cancer survival 
[20]; signifying the importance of healthy lifestyles.
As part of the on-going WCRF International Continuous 
Update Project (CUP) [21], we conducted a comprehensive 
systematic review and meta-analysis of the associations 
between adulthood physical activity, sedentary behavior, 
body mass index (BMI), waist and hip circumferences, 
waist-to-hip ratio, and weight change and the risk of over-
all and estrogen receptor (ER) and/or progesterone receptor 
(PR)-defined pre- and postmenopausal breast cancer, for 
which previous evidence has suggested complex differential 
associations [22–24]. These data contributed to the scientific 
evidence for the development of cancer prevention recom-
mendations in the WCRF/AICR Third Expert Report [8]. 
Here, we describe the current knowledge and our findings.
Materials and methods
Full details of the methods used in the present review are 
available online in the supplementary material.
Literature search
Relevant publications were searched in PubMed up to 30th 
April 2017, using a tested search strategy with no language 
restriction. Reference lists of related articles were screened.
Study selection
Inclusion criteria were (1) randomized controlled trials, 
cohort studies, case–cohort studies, case–control studies 
within a cohort, or pooled analyses of individual data from 
studies of these designs; (2) studies that investigated the 
associations of interest; and (3) studies reporting relative 
risk, hazard ratio, or odds ratio and its measure of variability.
The publication with more number of cases was selected 
from multiple publications of the same study or studies of 
overlapping populations. Pooled analyses that combined 
case–control studies with cohort studies were excluded [25, 
26].
Data extraction
Study characteristics, participant characteristics, exposure 
factors and breast cancer outcomes, numbers of cases and 
non-cases per exposure category, relative risk estimates 
(RR) with their 95% confidence intervals (CI) or p-values, 
and covariate adjustment in the analysis were extracted into 
the CUP database.
Study quality evaluation
The risk of bias of the included studies was assessed for 
various aspects relating to menopausal status classification, 
exposure and outcome ascertainment, and confounding fac-
tors adjustment. Supplementary Table S1 shows the scoring 
criteria.
Statistical methods
The primary analysis was linear dose–response meta-analy-
sis, conducted when at least three studies report the required 
information on an association. A summary RR was calcu-
lated using a random-effects model, which allows for pos-
sible variations of associations across the studies [27].
The procedures to pool the results from individual stud-
ies were in accordance with other published meta-analyses 
[28–31]. This involved the pooling of dose–response esti-
mates that were either directly reported in the studies or 
calculated by us for the studies reporting RR estimates for 
at least three exposure levels using the generalized weighted 
least-squares regression model [32, 33]. In this method, 
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numbers of cases and non-cases or population at risk and 
exposure values (mean or midpoint of range) per category 
are needed. If the required information was not available, 
standard methods were used to impute these [34, 35]; if this 
could not be done, the study was excluded from the meta-
analysis (insufficient data).
For physical activity (any domains) and adulthood weight 
loss, because the required data for dose–response trend esti-
mation were not reported in most studies, random-effects 
categorical meta-analyses that compared the highest with 
the lowest level were also conducted.
Multivariable adjusted estimates were selected for the 
meta-analyses. Between-study heterogeneity was assessed 
by the Cochran Q test, and I2 statistic [36], and potential 
heterogeneity sources were explored in pre-defined subgroup 
meta-analyses and univariate meta-regression analyses [37]. 
Small study bias such as publication bias was assessed by 
Egger’s test and visual inspection of the funnel plots when 
there were more than ten studies [38]. Influence analysis 
was conducted by omitting each study in turn from the 
meta-analysis. Exploratory non-linear dose–response meta-
analysis was conducted when there were five or more studies 
with at least four exposure categories, using restricted cubic 
spline regression with three knots [39, 40].
A two-tailed p-value of < 0.05 was considered as statisti-
cal significant, except for the p-value of < 0.10 in the gener-
ally low-powered Egger’s test [38]. Statistical package Stata 
13.1 (StataCorp, College Station, TX, USA) was used.
Results
Figure 1 shows the PRISMA flowchart. Overall, 142 publi-
cations from 126 observational cohort studies, comprising 
over 22,900 premenopausal and 103,000 postmenopausal 
breast cancer cases among 8.53 million women, mostly 
from North America and Europe, and some from Australia 
and New Zealand, China, Korea, and Japan were meta-ana-
lyzed [14, 41–181]. No randomized controlled trials were 
identified.
Figures 2, 3, 4, and 5 show the results of the meta-analy-
ses. Supplementary materials: Table S2 is the list of studies 
included and excluded with exclusion reason from the meta-
analyses, Table S3 shows the main characteristics of the 
included studies, Table S4 is the PRISMA checklist, Tables 
S5 to S17 show the results of the subgroup meta-analyses, 
and Figs. S1 to S52 are the graphical results of the analyses.
Physical activity and premenopausal breast cancer
Vigorous physical activity was statistically significantly 
inversely associated with premenopausal breast cancer 
risk when comparing the highest with the lowest level. 
The summary RR was 0.79 (95% CI 0.69–0.91), with 
low between-study heterogeneity (I2 = 6%, p heteroge-
neity = 0.37) (5 studies) (Fig. S1). The associations were 
inverse but not significant for total physical activity (recrea-
tional, household, occupational physical activity combined) 
(5 studies), recreational (12 studies), and occupational physi-
cal activity (8 studies). There was no association with walk-
ing (2 studies) (Figs. 2 and S2–S5).
The associations were not significantly different in 
the subgroup meta-analyses (p-values for meta-regres-
sion ≥ 0.10) (Tables S5 and S6). Dose–response meta-anal-
yses were possible for vigorous and recreational physical 
activity (3 studies each). The results were not significant 
(Figs. 3 and S6–S7). In influence analyses, the association 
became non-significant for vigorous physical activity but 
remained unchanged for the other domains. There was no 
indication of small study bias (Egger’s test p = 0.89).
Physical activity and postmenopausal breast cancer
Significant inverse associations for physical activity and 
postmenopausal breast cancer risk were observed across 
all domains in the highest versus the lowest meta-analyses, 
except for walking (Fig. 2). The summary RRs were 0.90 
(95% CI 0.85–0.95; I2 = 0%, p heterogeneity = 0.96) (11 
studies) for vigorous, 0.86 (0.78–0.94; I2 = 9%, p heteroge-
neity = 0.35) (6 studies) for total, 0.88 (0.82–0.94; I2 = 35%, 
p heterogeneity = 0.06) (21 studies) for recreational, 0.90 
(0.85–0.96; I2 = 0%, p heterogeneity = 0.89) (9 studies) for 
occupational physical activity, and 0.95 (0.86–1.04; I2 = 0%, 
p heterogeneity = 0.98) (4 studies) for walking (Figs. S1–S5).
In the subgroup meta-analyses by BMI, recreational 
physical activity was non-significantly inversely associ-
ated with postmenopausal breast cancer among women 
of normal weight (summary RR 0.85, 95% CI 0.72–1.01) 
(5,946 cases), and weaker or no associations were observed 
among women who were overweight (0.95, 0.85–1.06) 
(3,548 cases) or obese (1.00, 0.86–1.15) (1,803 cases) (p 
for meta-regression = 0.53) (5 studies [67, 122, 128, 138, 
160]) (Fig. S9). The inverse associations were more evident 
among postmenopausal hormone never users [56, 92, 128, 
138, 139] than ever users [56, 92, 128, 138, 139, 164]; and 
for vigorous physical activity, stronger for postmenopausal 
ER− [110, 139] than ER+ [108, 110, 139, 141] breast can-
cers (Figs. S10–S13). Meta-analyses of the other subgroups 
mostly confirmed the inverse associations (p-values for 
meta-regression ≥ 0.05) (Tables S5–S7).
Limited numbers of studies could be included in the 
dose–response meta-analyses (Fig. 3). The summary RR 
was 0.98 (95% CI 0.97–0.99) per 10 metabolic equivalent 
of task (MET)-hour/week of recreational physical activity (6 
studies). Non-significant associations of similar magnitude 
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were observed for total and vigorous physical activity (3 
studies each) (Figs. S6-S8).
Non-linear analysis showed no departure from linearity 
(p = 0.68) (Fig. S14). The association with total physical 
activity became non-significant but the summary estimate 
was unchanged (RR for highest versus lowest level 0.86, 
95% CI 0.74–1.00) when one study [160] was omitted 
from influence analysis. Small study bias was detected in 
the analysis of recreational physical activity (Egger’s test 
p = 0.01). Smaller studies with a stronger than the average 
inverse association [42, 133, 155, 182] and one study with 
Fig. 1  PRISMA flowchart: 
studies of physical activity, 
sedentary behavior, adiposity, 
and weight change and breast 
cancer risk
1 928 publications excluded: 
656 reviews/no original data  
150 meta-analyses 
118 editorial/commentary/abstract  
503 out of research topic 
428 case-control studies 
73 other study designs 
42 403 publications excluded on the 
basis of title and abstract
2 392 publications retrieved and assessed for 
inclusion 
44 795 potentially relevant publications 
identified in PubMed during June 1, 2008 and 
April 30, 2017  
556 additional publications from the 
searches (WCRF Second Expert 
Report and pilot CUP update) prior to 
June 1, 2008
464 publications included from the search 
1020 publications relevant to the WCRF 
Continuous Update Project (CUP) 
682 publications not on physical 
activity, adiposity, and/or weight 
change were excluded
338 publications potentially relevant to the 
present systematic review and meta-analysis
Overall 142 publications included in the 
respective meta-analysis of pre- and 
postmenopausal breast cancer: 
   5 and 6 studies on total physical activity 
   12 and 21 studies on recreational activity 
   5 and 11 studies on vigorous activity 
   8 and 9 studies on occupation activity 
   2 and 4 studies on walking, and on sitting 
  13 and 18 studies on early adult body mass index 
   9 and 16 studies on adult weight gain 
   6 and 9 studies on gain in body mass index 
   8 and 14 studies on weight loss 
   40 and 75 studies on body mass index 
   7 and 23 studies on waist circumference 
   4 and 16 studies on hip circumference 
   10 and 29 studies on waist-hip-ratio 
196 publications were not in any meta-
analysis: 
100 publications on BC of 
unspecified menopausal status 
64 publications superseded by 
publications of the same or 
overlapping study 
9 publications presented 
insufficient data or had no RR 
estimate 
23 publications not meta-analysed 
due to low number of studies 
overall 
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a weaker association [160] may have driven the asymmetry 
in the funnel plot.
Sedentary behavior and premenopausal 
and postmenopausal breast cancer
Increased total sitting time was not associated with pre-
menopausal breast cancer (2 studies) (Fig. 2). However, it 
was positively associated with postmenopausal breast can-
cer. The summary RRs were 1.20 (95% CI 1.00–1.44) for 
the highest versus the lowest level (I2 = 46%, p heterogene-
ity = 0.13) (4 studies) (Fig. 2) and 1.07 (95% CI 1.01–1.14) 
per 5 h/day (I2 = 0%, p heterogeneity = 0.55) (3 studies) 
(Fig. 3). The associations were not observed for sitting while 
watching television or at work (Figs. S15–S17) and did not 
persist in influence analyses.
Early adult body mass index and premenopausal 
and postmenopausal breast cancer
Greater early adult BMI (ages 18–30 years) was significantly 
inversely associated with premenopausal breast cancer. The 
summary RR was 0.86 (95% CI 0.78–0.96) per 5 kg/m2 
(I2 = 47%, p heterogeneity = 0.05) (13 studies) (Figs. 3 and 
S18).
Inverse association of similar magnitude was observed 
for postmenopausal breast cancer (0.81, 0.75–0.87) (Figs. 3 
and S18). There was significant between-study heterogene-
ity (I2 = 50%, p heterogeneity = 0.01) (18 studies). Subgroup 
meta-analyses showed that studies that adjusted for adult 
BMI or weight gain [68, 87, 99, 136, 154, 162] on aver-
age observed a stronger inverse association compared with 
unadjusted studies [54, 56, 102, 111, 113, 130, 167, 170, 
178], and may partially explain the observed heterogeneity 
Fig. 2  Summary risk estimates 
of pre- and postmenopausal 
breast cancer for the highest 
versus the lowest categories of 
physical activity, adiposity, and 
weight change
Vigorous activity
Premenopausal
Postmenopausal
Total activity
Premenopausal
Postmenopausal
Recreational activity
Premenopausal
Postmenopausal
Occupational activity
Premenopausal
Postmenopausal
Walking
Premenopausal
Postmenopausal
Total sitting
Premenopausal
Postmenopausal
Sitting, watching TV
Premenopausal
Postmenopausal
Sitting at work
Postmenopausal
Adult weight loss
Premenopausal
Postmenopausal
breast cancer
Lifestyle factor/
0.79 (0.69, 0.91)
0.90 (0.85, 0.95)
0.93 (0.79, 1.08)
0.86 (0.78, 0.94)
0.89 (0.75, 1.04)
0.88 (0.82, 0.94)
0.83 (0.65, 1.05)
0.90 (0.85, 0.96)
0.97 (0.76, 1.25)
0.95 (0.86, 1.04)
1.04 (0.83, 1.32)
1.20 (1.00, 1.44)
0.92 (0.71, 1.18)
1.06 (0.98, 1.15)
0.98 (0.72, 1.35)
0.85 (0.74, 0.99)
0.90 (0.81, 0.99)
RR (95% CI)
Summary
5/3353
11/20,171
5/1834
6/9755
12/>3937
21/>27,224
8/5339
9/21,932
2/1289
4/7300
2/1290
4/4704
2/1290
4/9038
2/1720
8/1373
14/8282
cases
Studies/
6%
0%
0%
9%
40%
35%
76%
0%
17%
0%
0%
46%
0%
0%
77%
0%
24%
I2
1.6 .7 .8 .9 1.1 1.3 1.5
Relative risk
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(p-value for meta-regression = 0.009). Inverse associations 
persisted across most other subgroups (p-values for meta-
regression ≥ 0.08) (Table S8).
There were no indications of non-linear relationships 
(p ≥ 0.29) (Figs. S19–S20) or small study bias (p ≥ 0.13).
Body mass index and premenopausal breast cancer
Greater BMI (study baseline) was significantly inversely 
associated with premenopausal breast cancer. The summary 
RR was 0.94 (95% CI 0.91–0.98) per 5 kg/m2 (I2 = 59%, p 
heterogeneity < 0.001) (40 studies) (Figs. 3 and S21).
The observed heterogeneity may partially be explained by 
study location (p for meta-regression = 0.004). On average, 
the association was significant and inverse in European stud-
ies [47, 49, 66, 97, 106, 114, 115, 119, 120, 143, 168, 169, 
171, 173, 175], non-significant and inverse in North Ameri-
can studies [56, 57, 80, 136, 144, 159, 171, 180], but non-
significant and positive in Asian studies (8 Japanese studies 
[174] and 1 Chinese study [112]) (Table S9).
BMI was not significantly associated with premenopausal 
ER+ and ER− breast cancers (5 studies, 4 publications [57, 
65, 95, 127]) (Fig. S22).
There was no indication of departure from linearity 
(p = 0.31) (Fig. S23). The funnel plot showed asymmetry, 
probably driven by study heterogeneity (p = 0.06). BMI was 
not associated with premenopausal breast cancer mortality 
(36 studies, 2 publications [143, 179]) (Fig. S24).
Fig. 3  Summary risk estimates 
of pre- and postmenopausal 
breast cancer per unit increment 
of physical activity, adiposity, 
and weight change
Vigorous physical activity, per 30 mins/day
Premenopausal
Postmenopausal
Total physical activity, per 20 MET−hrs/wk
Postmenopausal
Recreational physical activity, per 10 MET−hrs/wk
Premenopausal
Postmenopausal
Total sitting, per 5 hrs/day
Postmenopausal
Sitting, watching TV, per 2 hrs/day
Postmenopausal
Early adult BMI, per 5 kg/m2
Premenopausal
Postmenopausal
BMI, per 5 kg/m2
Premenopausal
Postmenopausal
Adult weight gain, per 5 kg
Premenopausal
Postmenopausal
Gain in BMI, per 5 kg/m2
Premenopausal
Postmenopausal
Adult weight loss, per 5 kg
Postmenopausal
Waist circumference, per 10 cm
Premenopausal
Postmenopausal
Hip circumference, per 10 cm
Premenopausal
Postmenopausal
Waist−hip−ratio, per 0.1 unit
Premenopausal
Postmenopausal
breast cancer
Lifestyle factor/
0.91 (0.83, 1.01)
0.94 (0.86, 1.02)
0.98 (0.96, 1.00)
0.96 (0.90, 1.03)
0.98 (0.97, 0.99)
1.07 (1.01, 1.14)
1.01 (0.99, 1.04)
0.86 (0.78, 0.96)
0.81 (0.75, 0.87)
0.94 (0.91, 0.98)
1.12 (1.10, 1.15)
1.00 (0.97, 1.03)
1.07 (1.05, 1.09)
0.97 (0.77, 1.22)
1.17 (1.11, 1.23)
0.96 (0.88, 1.04)
0.99 (0.94, 1.03)
1.11 (1.08, 1.14)
0.92 (0.87, 0.98)
1.06 (1.04, 1.09)
1.05 (0.98, 1.13)
1.10 (1.05, 1.16)
RR (95% CI)
Summary
3/1473
3/2853
3/2539
3/2331
6/19,816
3/4333
4/9038
13/>4498
18/>9271
40/>16,486
75/>91,507
9/3990
16/17,150
6/>900
9/>2575
4/952
7/2836
23/17,350
4/1438
16/5391
10/3645
29/17,741
cases
Studies/
0%
0%
61%
69%
0%
0%
0%
47%
50%
59%
76%
21%
64%
75%
0%
0%
0%
44%
0%
0%
14%
60%
I2
1.6 .7 .8 .9 1.1 1.3
Relative risk
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Body mass index and postmenopausal breast cancer
Greater BMI was significantly positively associated with 
postmenopausal breast cancer. The summary RR was 1.12 
(95% CI 1.10–1.15) per 5 kg/m2 (I2 = 76%, p heterogene-
ity < 0.001) (75 studies) (Figs. 3 and S21).
Study location may partially explain between-study heter-
ogeneity (p for meta-regression < 0.001). Asian studies [59, 
86, 112, 158, 174] showed an average stronger positive asso-
ciation than studies from Europe [46, 47, 49, 63, 66, 72, 79, 
88, 91, 96, 97, 115, 120, 125, 143, 153, 168, 169, 171, 172], 
North America [44, 51, 56, 57, 75, 80, 81, 98, 100, 101, 
136, 152, 159, 167, 171, 178], and Australia and New Zea-
land [68, 135] (Table S9). Positive associations were evident 
among never [56, 72, 130, 136, 143, 162, 171, 178], former 
[178], and never/former [41, 75, 85, 106] postmenopausal 
hormone users but not current [41, 75, 85, 106, 177, 178] or 
ever [56, 72, 102, 130, 162, 171] postmenopausal hormone 
users (p for meta-regression = 0.002) (Figs. 4 and S25).
The associations were different between the HR subtypes, 
with positive associations observed for postmenopausal 
ER+ [57, 65, 82, 84, 95, 100, 102, 141, 154], PR+ [50, 95, 
102, 154], and ER+ PR+ [41, 55, 95, 102, 132, 136, 148, 
156, 161, 177] breast cancers, and non-significant associa-
tions for ER− [57, 60, 65, 82, 95, 100, 102, 154], PR- [50, 
95, 102, 154], ER−PR− [41, 55, 95, 102, 132, 136, 148, 
156, 161, 177], ER+ PR− [41, 55, 73, 102, 132, 156, 161], 
and ER−PR+ [73] breast cancers (Figs. 5 and S26–S27).
In non-linear analysis, the estimated RRs for women who 
were overweight (27.5 kg/m2) and obese (32.5 kg/m2) were 
1.16 (95% CI 1.10–1.22) and 1.29 (1.19–1.39), respectively, 
compared with women who were normal weight (21.7 kg/
m2) (p = 0.31) (Fig. S28). Small study bias was detected 
(p = 0.04). Asymmetry in the funnel plot was driven by a 
few studies reporting stronger than the average positive asso-
ciation [79, 80, 86, 112, 158, 159, 174]. BMI was positively 
associated with postmenopausal breast cancer mortality 
(1.21, 1.15–1.28) (39 studies [48, 132, 140, 143, 179]) (Fig. 
S29).
Adult weight gain and BMI gain and premenopausal 
and postmenopausal breast cancer
Adult weight gain and BMI gain (from aged 18 years to 
study baseline) were not associated with premenopausal 
breast cancer (9 studies and 6 studies, respectively) (Figs. 3 
Fig. 4  Summary risk estimates 
of effect modification by post-
menopausal hormone use in the 
associations of adiposity and 
weight change with postmeno-
pausal breast cancer
Adult weight gain, per 5 kg
MHT never
MHT never/former
MHT current
MHT ever
BMI, per 5 kg/m2
MHT never
MHT never/former
MHT current
MHT ever
Waist circumference, per 10 cm
MHT never
MHT never/former
MHT current
MHT ever
Waist−hip−ratio, per 0.1 unit
MHT never
MHT current
MHT ever
Subgroup
1.06 (1.03, 1.09)
1.09 (1.07, 1.12)
1.00 (0.98, 1.03)
1.08 (1.00, 1.16)
1.16 (1.10, 1.23)
1.20 (1.15, 1.25)
0.98 (0.92, 1.05)
1.01 (0.96, 1.06)
1.10 (0.96, 1.23)
1.15 (1.10, 1.21)
1.02 (0.96, 1.09)
1.01 (0.93, 1.10)
1.12 (0.98, 1.27)
0.97 (0.88, 1.07)
0.98 (0.86, 1.11)
RR (95% CI)
Summary
4/1431
3/2756
3/2370
3/626
15/>10487
4/3369
6/4221
13/>3004
8/947
2/1706
2/1111
7/1135
7/660
2/1071
6/875
cases
Studies/
0%
37%
19%
44%
72%
0%
62%
0%
69%
26%
0%
32%
0%
10%
0%
I2
1.8 .9 1.1 1.3 1.5
Relative risk
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and S30-S31). There was statistical evidence of non-linearity 
(p = 0.03), but no significant association was observed along 
the curve (Fig. S32).
Positive associations were observed for postmenopau-
sal breast cancer. The summary RRs were 1.07 (95% CI 
1.05–1.09) per 5 kg (I2 = 64%, p heterogeneity < 0.001) 
(16 studies) and 1.17 (1.11–1.23) per 5 kg/m2 (I2 = 0%, p 
heterogeneity = 0.81) (9 studies) (Figs. 3 and S30–S31).
None of the subgroup analyses could clearly explain the 
observed heterogeneity (Tables S10 and S11). Asian stud-
ies [99, 133, 183] on average showed a stronger, but not 
significantly different, positive association than Australian 
[102], European [43, 107, 170], or American studies [41, 
52, 56, 75, 77, 136, 142, 178, 181] (p for meta-regres-
sion = 0.06). Different associations by postmenopausal 
hormone use were observed (p for meta-regression = 0.01), 
but the status used in the studies overlapped (positive asso-
ciations among never [56, 102, 136, 142], never/former 
[41, 75, 107], and ever users [56, 102, 142]; null associa-
tion among current users [41, 75, 107]) (Figs. 4 and S33).
Adult weight gain was significantly positively associ-
ated with ER+ PR+ breast cancers [41, 55, 74, 102, 136, 
150] but not with ER+ /PR− [41, 55, 102, 150] or ER-/
PR- [41, 55, 74, 102, 136, 150] breast cancers in post-
menopausal women (Figs. 5 and S34).
No deviation from linearity was detected (p = 0.75) 
(Fig. S35), but there was evidence of small study bias 
(p = 0.04). Asymmetry in the funnel plot was possibly 
driven by a small study [52] and Asian studies [99, 133] 
showing stronger positive associations.
Adult weight loss and BMI loss and premenopausal 
and postmenopausal breast cancer
Inverse associations were observed for both pre- and post-
menopausal breast cancers when comparing any weight 
loss (of unknown intention, from aged 18 years to study 
baseline) with stable weight. The summary RRs were 
0.85 (95% CI 0.74–0.99; I2 = 0%, p heterogeneity = 0.93) 
(8 studies) and 0.90 (0.81–0.99; I2 = 24%, p heterogene-
ity = 0.20) (14 studies), respectively (Figs. 2 and S36). 
There was no clear pattern of differences between the 
subgroups (Table S12). Dose–response meta-analysis was 
possible for postmenopausal breast cancer (4 studies). The 
result was not significant (Fig. S37). Results similar to the 
main findings were observed in influence analyses, but the 
statistical significance was lost. There was no evidence of 
small study bias (Egger’s test p = 0.26).
Fig. 5  Summary risk estimates 
of hormone receptor-defined 
postmenopausal breast cancer 
per unit increment of adiposity 
and weight change
Adult weight gain, per 5 kg
ER+PR+
ER−PR−
ER+PR−
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ER−negative
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Waist and hip circumferences, and waist‑to‑hip ratio 
and premenopausal breast cancer
Higher waist circumference was not associated with pre-
menopausal breast cancer. The per 10-cm increase summary 
RR was 0.99 (95% CI 0.94–1.03; I2 = 0%, p heterogene-
ity = 0.88) (7 studies) (Fig. 3); however, in studies further 
adjusted for BMI (4 studies [89, 94, 106, 177]), there was 
an average positive association (1.15, 1.05–1.26) (Fig. S38).
For hip circumference, there was a significant inverse 
association (0.92, 0.87–0.98 per 10 cm; I2 = 0%, p heteroge-
neity = 0.50) (4 studies) (Fig. 3); but a non-significant asso-
ciation in BMI adjusted studies (1.05, 0.80–1.36) (3 studies 
[89, 94, 106]) (Fig. S39).
For waist-to-hip ratio, there was a non-significant associa-
tion (1.05, 0.98–1.13 per 0.1 unit; I2 = 14%, p heterogene-
ity = 0.31) (10 studies) (Fig. 3); and a borderline positive 
association in BMI adjusted studies (1.14, 1.00–1.29) (7 
studies [89, 94, 106, 112, 131, 159, 177]) (Fig. S40).
Results were similar across the subgroups (Tables 
S13–S15). Non-linear analyses showed no departure from 
linearity, but the 95% CIs were wide because of little data 
(p ≥ 0.07) (Figs. S41–S43). There was no indication of small 
study bias (p = 0.25).
Waist and hip circumferences, and waist‑to‑hip ratio 
and postmenopausal breast cancer
Postmenopausal breast cancer risk was significantly posi-
tively associated with all adiposity measures evaluated. The 
summary RRs were 1.11 (95% CI 1.08–1.14; I2 = 44%, p 
heterogeneity = 0.04) per 10 cm of waist circumference (23 
studies), 1.06 (1.04–1.09; I2 = 0%, p heterogeneity = 0.48) 
per 10  cm of hip circumference (16 studies), and 1.10 
(1.05–1.16; I2 = 60%, p heterogeneity < 0.001) per 0.1 unit 
of waist-to-hip ratio (29 studies) (Fig. 3). In BMI adjusted 
studies, the association was attenuated for waist circumfer-
ence (1.07, 1.01–1.13) (7 studies [79, 82, 94, 98, 106, 154, 
177]), lost statistical significance for hip circumference 
(1.12, 0.95–1.32) (3 studies [79, 94, 106]), and waist-to-hip 
ratio (1.05, 0.98–1.13) (8 studies [79, 94, 106, 112, 131, 154, 
159, 177]) (Figs. S44-S46).
The positive association was stronger in European [46, 
79, 97, 145] and North American studies [41, 56, 76, 82, 
94, 98, 101, 136] than Australian and New Zealand stud-
ies (10 studies, 1 publication [135]) (p for meta-regres-
sion = 0.04) (Table S13); and was more evident among never 
or former users [41, 56, 79, 82, 130, 136] than current or 
ever users [41, 56, 79, 130, 177] of postmenopausal hor-
mones (p-values for meta-regression ≥ 0.06) (Figs. 4 and 
S47–S48). There were no indications of non-linear relation-
ship (p-values ≥ 0.06) (Figs. S49–S52) or small study bias 
(p-values ≥ 0.25).
Quality of studies included in the meta‑analyses
Most studies used record linkage to ascertain cancer cases 
and met the required quality aspects (Figs. S53–56), and 
were considered average to good quality. Higher or lower 
risk of bias studies on average did not found significantly 
different associations in the subgroup meta-analyses (Tables 
S5–S17).
Discussion
Summary of findings
The present systematic literature review and meta-analysis 
demonstrates the complex associations between adulthood 
energy balance-related factors and breast cancer risk in pre- 
and postmenopausal women.
Higher physical activity, in particular recreational physi-
cal activity, was associated with reduced risk of pre- and 
postmenopausal breast cancer, although there were less 
data on premenopausal women. The risk reduction was 
observed at high levels similar to the prolonged moderate 
physical activity of 45 to 60 min daily suggested for weight 
maintenance [184]. Physical activity may operate through 
obesity-related biological pathways or mechanisms that 
involve immunity and defense [7, 185], which could explain 
the observed inverse associations for both postmenopausal 
ER+ and ER− breast cancers. Strenuous physical activity 
before menarche may delay the onset of menstruation and 
increase anovulatory cycles in young women [186]. In the 
present meta-analysis, significant inverse association was 
observed among normal weight women. It is unclear if 
the lack of association in overweight or obese women is 
due to low number of women with the required physical 
activity level or if any independent effect of physical activ-
ity is masked by excessive body adiposity. Previously, the 
National Cancer Institute Cohort Consortium (35,178 breast 
cancer cases overall) reported inverse associations in women 
of BMI < 25 and ≥ 25 kg/m2, with no effect modification 
[187]. Confirmation is needed in pre- and postmenopausal 
women. Sedentary behavior, represented by sitting time, was 
associated with an increased risk of postmenopausal breast 
cancer. Excessive sitting reduces overall energy expenditure 
and contributes to obesity [188, 189], but could also be an 
independent risk factor for breast cancer [190].
Higher early adult BMI (ages 18–30 years) was inversely 
associated with both pre- and postmenopausal breast can-
cers. The results corroborate with the inverse association 
published recently by the Premenopausal Breast Cancer Col-
laborative Group of 19 cohort studies [191] (5 studies are in 
common with the present meta-analysis [56, 113, 136, 175, 
180]). The study also reported risk reductions for ER+ and 
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ER− breast cancers in premenopausal women [191], which 
are potentially driven by estrogen-induced early breast dif-
ferentiation [192] and slower pubertal growth [193] that may 
reduce the susceptibility to carcinogens in the breast tissue 
of young girls with higher adiposity.
Weight loss was inversely associated with pre- and post-
menopausal breast cancer. The results were not robust, and 
the intentionality of weight loss and potential weight regain 
were largely not known in the studies. The present findings 
require further confirmations, although studies of stable 
weight loss and bariatric surgery have shown postmenopau-
sal breast cancer risk reduction [70, 194, 195], and partici-
pants who lost weight or body fat in randomized controlled 
trials have demonstrated favorable changes in hormonal and 
metabolic profiles [196–198].
Weight gain (from aged 18  years to study baseline) 
and subsequent excessive body adiposity (total adiposity, 
assessed by BMI at study baseline; abdominal adiposity, 
assessed by waist circumference, and waist-to-hip ratio; 
and gluteo-femoral adiposity, assessed by hip circumfer-
ence) consistently increased the risk of breast cancer in 
postmenopausal women. Non-linear analyses did not reveal 
any threshold, indicating any weight gain after early adult 
years may lead to increased risk. The associations were 
more evident for HR+ but not HR- postmenopausal breast 
cancers; and among never but not current users of post-
menopausal hormones, probably because exogenous estro-
gens, a strong risk factor of postmenopausal breast cancer 
[199], have masked the effect of the hormones synthesized 
in adipose tissue. Recent publications reported largely sup-
portive results. These included the different age-specific 
associations with baseline BMI for the risk of luminal-like 
and triple-negative breast cancers reported by the National 
Cancer Institute Cohort Consortium (9 cohorts) [200], and 
the strong positive associations between different adiposity 
measures and breast cancer risk in long-term postmenopau-
sal women reported by the UK Biobank Prospective Cohort 
Study [201].
The evidence was less consistent in premenopausal 
women. In the present meta-analysis, we observed no asso-
ciation with adult weight gain, but weight gain between 40 
and 50 years has been reported to increase premenopausal 
breast cancer risk [72]. Since middle age is a period when 
more fat is deposited viscerally [202], it is possible that 
timing, duration, as well as location of fat deposition are 
important factors for breast cancer development. Higher 
adult BMI (study baseline) was inversely associated with 
breast cancer risk in premenopausal women, although there 
was a lack of consistency across the study results. One possi-
ble explanation is the positive association observed in Asian 
studies [112, 174]. Asian women tend to be more prone to 
visceral fat accumulation than their Western counterparts 
[203], but further replication of the result is needed. In terms 
of abdominal obesity, we observed non-significant associa-
tions that were reverted to positive associations in studies 
accounting for total adiposity; since total and abdominal 
adiposity are highly correlated [41, 145, 159, 165], the sug-
gested independent effect requires confirmation. There were 
no significant associations for HR-defined premenopausal 
breast cancers, but the meta-analyses included few studies.
Mechanistically, increased expression of aromatase in adi-
pose tissue of postmenopausal women with obesity increases 
conversion of androgens to estrogens that induce tumor cell 
proliferation and inhibit apoptosis [204, 205]; whereas 
lowered concentrations of progesterone in premenopausal 
women with obesity mitigate estrogen-induced proliferation 
in breast epithelial cells [206], albeit inconsistent findings 
on progesterone and breast cancer [207–209]. Studies on 
gene expression patterns in breast tissue have shown that 
as body weight increases, there is increased breast cancer 
cell proliferation in postmenopausal women but decreased 
proliferation in premenopausal women [210]. Abdominal 
obesity is frequently associated with insulin resistance and 
hyperinsulinemia [211, 212]. Insulin and insulin-like growth 
factor-I are mitogenic. Insulin also inhibits sex hormone-
binding globulin synthesis, leading to higher concentrations 
of free oestradiol [205]. Other proposed mechanisms that 
link obesity to breast cancer include increased concentra-
tions of proinflammatory cytokines and leptin that induce 
aromatization and reduced concentrations of adiponectin 
that has anti-inflammatory and insulin-sensitizing ability 
[205, 213–215].
Our findings are generally in agreement with those of 
published umbrella reviews of the literature evidence on 
physical activity and adiposity with cancer risk [216–218], 
but are opposite to the results of Mendelian randomiza-
tion (MR) studies. Recent publications from large-sized 
MR studies reported inverse associations with genetically 
predicted adiposity for the risk of breast cancer, overall 
[219] and in premenopausal [220–222] and postmenopau-
sal women [220, 222], which were not shown in an earlier 
small study [47]. One possible explanation is that genetically 
predicted adiposity may be more closely related to early life 
adiposity than later life adiposity that is largely influenced 
by the environment. One MR study provided causal evidence 
that higher childhood adiposity reduces breast cancer risk 
[219].
Study limitations
Several limitations in the present review require discussion. 
There may be some level of misclassification of cancer as 
pre- or postmenopausal depending on whether the required 
information was taken at study baseline or cancer diagnosis; 
however, subgroup meta-analyses by timing of classifica-
tion mostly did not show significantly different associations. 
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Premenopausal breast cancer studies that used baseline 
information on average found an inverse association with 
adult BMI, opposite to the positive association in postmeno-
pausal studies.
The association with physical activity may have been 
underestimated due to measurement error, as frequency, 
intensity, and type of activity were poorly characterized in 
most studies. Attenuation of the associations due to regres-
sion dilution is possible as most studies had long follow-up 
(≥ 10 years) and collected information at baseline. Recall 
or other biases in weight change and weight at early age 
are also possible. While BMI—a practical measure of total 
adiposity—is predictive of health outcomes on a population 
level, it does not reflect fat distribution or differentiates lean 
from fat mass that varies across women of different age and 
ethnicity [223].
Data on pre- and postmenopausal hormone receptor-
defined breast cancers were limited. Information on type of 
postmenopausal hormone use was not available for meta-
analysis. A few studies did not report data sufficient for the 
meta-analysis [224–230]; nevertheless, most excluded stud-
ies reported concordant findings with the meta-analyses.
Strength of the study and future research
The present systematic literature review is extensive and 
comprehensive, in that all known existing scientific evi-
dence from observational cohort studies—a design that is 
less prone to recall and selection biases than case–control 
studies [9]—on different domains of physical activity, sed-
entary behavior, adiposity measures, and weight change in 
different periods of adulthood in relation to breast cancer 
risk by menopausal status and hormone receptor subtype 
were summarized. Most meta-analyses comprised more than 
900 breast cancer cases from at least three cohort studies that 
were of average to good quality.
With the accumulated evidence, we were able to explore 
the magnitude and the shape of the associations. Never-
theless, more longitudinal studies with repeated exposure 
assessments along the life course are needed, in women 
across all age range, and from different ethnic/racial groups 
who may have different risk patterns. Improved assessments 
for better quantification and characterization of exposure 
factors are needed, to evaluate their independent and joint 
effects on breast cancer development. Also, more studies 
are needed to clarify the different associations in molecular 
and clinical breast cancer subgroups. Randomized controlled 
trials, in particular weight loss trials and physical activity 
trials, are needed to provide definitive evidence for effective 
interventions to prevent breast cancer.
In conclusion, physical activity reduces breast cancer 
risk in both pre- and postmenopausal women, whereas 
factors reflecting energy imbalance influence the risk 
differently along the life course of the women. Although 
higher adiposity at early adulthood may reduce pre- and 
postmenopausal breast cancer risk, weight gain and exces-
sive adiposity later in life increase the risk, consistently in 
postmenopausal women and evidently for HR+ but not for 
HR− postmenopausal breast cancers. Under precaution-
ary principle, women should aim to be physically active 
(at least 150 min/week) and follow a lifestyle that leads 
to healthy body weight (BMI 18.5–24.9 kg/m2) for breast 
cancer prevention. Only about 25% of the public recognize 
the link between obesity and cancer [231]. Therefore, col-
lective effort—driven by public health policies [232]—is 
needed to promote healthy lifestyles for cancer prevention.
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